INS and fatty liver disease: These include: augmented oxidative stress, modified iron homeostasis [48, 79], activation of immunological and/or inflammatory processes leading to a disrupted cytokine imbalance [48, 80] and induction of hepatic steatosis, a risk factor in insulin sensitivity and related metabolic abnormalities [56].